The present invention relates to the following polycyclic aromatic derivative organic light emitting compound, and an organic light emitting device employing same as a dopant compound of a device light emitting layer. The organic light emitting device according to the present invention comprises a polycyclic aromatic derivative compound as a dopant compound in a light emitting layer, and also, at the same time, employs, alongside the dopant compound, an anthracene derivative compound having a characteristic structure in the light emitting layer by combining same as a host. Accordingly, the organic light emitting device according to the present invention has excellent color purity, high luminous efficiency, and a remarkably improved long life, and thus can be usefully used in various display devices.

The present disclosure provides a boron heterocyclic compound having a structure represented by a chemical formula 1, wherein L.sub.1 and L.sub.2 are each independently selected from the group consisting of C6-C30 aryl, C6-C30 fused aryl, C4-C30 heteroaryl, and C4-C30 fused heteroaryl; and R.sub.1 and R.sub.2 are each independently selected from the group consisting of carbazolyl, a carbazolyl-derived group, acridinyl, an acridinyl-derived group, diarylamino, and a diarylamino-derived group. The double boron heterocyclic structure functions as an electron acceptor and a linker. In the present disclosure, by attaching a group having a large steric hindrance to the boron atom of the boron heterocyclic ring, the molecules the compound are prevented from aggregating, and thus a π-aggregation or excimer formed by direct accumulation of the conjugate plane is avoided, thereby improving the light-emitting efficiency. The present disclosure further provides a display panel and a display apparatus. ##STR00001##

Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, and Formula V, or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.

Provided is an organic light-emitting device including a light-emitting layer comprising a compound of Chemical Formula 1, and a first organic material layer comprising a compound of Chemical Formula 2:

##STR00001## wherein: Cy1 to Cy5 are each independently one selected from the group consisting of a substituted or unsubstituted: aromatic hydrocarbon ring, aliphatic hydrocarbon ring, and an aromatic hetero ring, or a ring in which two or more rings selected from the above group are fused, one or more of Cy1 to Cy5 are a ring of the following Chemical Formula 1-A,

##STR00002##

wherein: Ar1 and Ar2 are the same as or different from each other, and are each independently a phenyl, a biphenyl, a terphenyl, a naphthyl, a phenanthrenyl, or a triphenylenyl, where the naphthyl, phenanthrenyl, and triphenylenyl can be substituted with a phenyl.

Provided is a compound of Formula I

##STR00001##

in which at least one moiety A, moiety B, moiety C, or moiety D is a 6-membered carbocyclic or heterocyclic ring, and at least one R.sup.A, R.sup.B, R.sup.C, or R.sup.D includes a group having Formula II

##STR00002##

where R.sup.X can be silyl, germyl, boryl, nitrile, F, CF.sub.3, cycloalkyl, heterocycloalkyl, or monocyclic heteroaryl. The compounds are useful as emitters in OLEDs providing improved efficiency.

A light emitting diode of one or more embodiments includes a first electrode, a second electrode opposite the first electrode, and at least one functional layer disposed between the first electrode and the second electrode, the at least one functional layer including a polycyclic compound represented by Formula 1 below, wherein the first electrode and the second electrode each independently includes at least one selected from among Ag, Mg, Cu, Al, Pt, Pd, Au, Ni, Nd, Ir, Cr, Li, Ca, LiF, Mo, Ti, W, In, Sn, Zn, compounds thereof, and mixtures thereof.

##STR00001##

The present disclosure provides for an organic electroluminescent device (OLED) including an anode; a cathode; and an emissive layer, disposed between the anode and the cathode. The emissive layer includes a phosphorescent dopant, a first host, and a second host, wherein the first host transports holes, the second host transports electrons, and the first host is fully or partially deuterated. Consumer products that include the OLED are also provided.

A compound is represented by a formula (1) below. D is a group represented by a formula (11), (12) or (13) below; at least one D is a group represented by the formula (12) or (13); at least one R is a substituent; and a sum of the number of R serving as a substituent and the number of a group represented by the formula (12) or (13) is 3 or 4.

##STR00001##

Activators may comprise compounds represented by the Formula [Ar(EHR.sup.1R.sup.2)(OR.sup.3)]d+[M.sup.k+Q.sub.n].sup.d, wherein: Ar is an aryl group; E is nitrogen or phosphorous; R.sup.1 is a C.sub.1-C.sub.30, optionally substituted, linear alkyl group; R.sup.2 is a C.sub.1-C.sub.30, optionally substituted, linear alkyl group; R.sup.3 is a C.sub.10-C.sub.30, optionally substituted, linear alkyl group; M is an element selected from group 13 of the Periodic Table of the Elements; d is 1, 2 or 3; k is 1, 2, or 3; n is 1, 2, 3, 4, 5, or 6; n−k=d; and each Q is independently hydride, bridged or unbridged dialkylamido, halide, alkoxide, aryloxide, hydrocarbyl, substituted hydrocarbyl, halocarbyl, substituted halocarbyl, or halosubstituted-hydrocarbyl radical. Catalysts systems may comprise these activators and methods of preparing polyolefins may use these catalysts systems.

A light-emitting device and an electronic apparatus (including the light-emitting device) are provided. The light-emitting device includes a first compound represented by Formula 1 and a second compound represented by Formula 2:

##STR00001##

wherein detailed descriptions of Formula 1 and Formula 2 are the same as described in the present specification.